This page shows the publications co-authored by Scott Lukas and Staci Gruber.
Gruber SA, Sagar KA, Dahlgren MK, Gonenc A, Smith RT, Lambros AM, Cabrera KB, Lukas SE. The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment. Front Pharmacol. 2017; 8:983.
Gruber SA, Sagar KA, Dahlgren MK, Racine MT, Smith RT, Lukas SE. Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function. Front Pharmacol. 2016; 7:355.
Gruber SA, Sagar KA, Dahlgren MK, Gonenç A, Conn NA, Winer JP, Penetar D, Lukas SE. Citicoline Treatment Improves Measures of Impulsivity and Task Performance in Chronic Marijuana Smokers: A Pilot BOLD fMRI Study. Int J Neurol Neurother. 2015 Sep 30; 2(3):1-8.
Gruber SA, Dahlgren MK, Sagar KA, Gönenç A, Lukas SE. Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology (Berl). 2014 Apr; 231(8):1455-65.
Gruber SA, Sagar KA, Dahlgren MK, Racine M, Lukas SE. Age of onset of marijuana use and executive function. Psychol Addict Behav. 2012 Sep; 26(3):496-506.
Li H, Smith SM, Gruber S, Lukas SE, Silveri MM, Hill KP, Killgore WDS, Nickerson LD. Denoising scanner effects from multimodal MRI data using linked independent component analysis. Neuroimage. 2020 03; 208:116388.
Hill KP, Palastro MD, Gruber SA, Fitzmaurice GM, Greenfield SF, Lukas SE, Weiss RD. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study. Am J Addict. 2017 Dec; 26(8):795-801.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.